a month ago
DNTH
AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Top 11%
#535 out of 5254 analysts
Average Return
+17.52%
Win Rate
49%48 out of 97
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +1,074.35% | $5.42 | $63.65 | 2024-10-10 - 2025-10-09 | Buy |
Palvella Therapeutics IncPVLA | +319.39% | $31.00 | $130.01 | 2025-07-21 - 2026-04-17 | Strong Buy |
Dianthus Therapeutics IncDNTH | +162.37% | $35.55 | $93.26 | 2025-10-14 - 2026-04-17 | Strong Buy |
Sage Therapeutics IncSAGE | +149.76% | $70.20 | $175.33 | 2017-05-16 - 2018-05-16 | Buy |
Centessa Pharmaceuticals PLCCNTA | +146.95% | $16.06 | $39.66 | 2025-07-21 - 2026-04-17 | Strong Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
2 months ago
BBIO
2 months ago
NBIX
3 months ago
CNTA
3 months ago
ARGX
3 months ago
NBIX
3 months ago
DNTH
3 months ago
CNTA
3 months ago
BBIO
4 months ago
PVLA
5 months ago
IRON
6 months ago
BBIO
6 months ago
ALNY
7 months ago
PVLA
2 years ago
SRPT
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | 2 | Strong Buy | $64.00 | +127.84% | Maintains | 6 days ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $505.00 | +63.08% | Maintains | 7 days ago |
Apogee Therapeutics IncAPGE | 1 | Hold | $83.00 | -9.98% | Initiates Coverage On | a month ago |
Climb Bio IncCLYM | 1 | Strong Buy | $17.00 | +85.59% | Initiates Coverage On | a month ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $110.00 | +17.95% | Maintains | a month ago |
Disc Medicine IncIRON | 7 | Strong Buy | $83.00 | +15.65% | Maintains | 2 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $95.00 | +23.78% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 9 | Strong Buy | $140.00 | +5.07% | Maintains | 2 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $38.00 | -4.19% | Maintains | 3 months ago |
Argenx SeARGX | 8 | Strong Buy | $1,030.00 | +21.31% | Maintains | 3 months ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $60.00 | +103.32% | Maintains | 3 months ago |
Immunovant IncIMVT | 6 | Hold | $22.00 | -24.91% | Maintains | 3 months ago |
Harmony Biosciences Holdings IncHRMY | 9 | Strong Buy | $45.00 | +50.05% | Maintains | 3 months ago |
Palvella Therapeutics IncPVLA | 4 | Strong Buy | $190.00 | +46.14% | Maintains | 4 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $47.00 | +370.47% | Initiates Coverage On | 6 months ago |
Jefferson Capital IncJCAP | 1 | Strong Buy | $24.00 | +12.78% | Initiates Coverage On | 9 months ago |
Uniqure NvQURE | 6 | Strong Buy | $52.00 | N/A | Upgrades | a year ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $79.00 | N/A | Reinstates | 2 years ago |
Regenxbio IncRGNX | 1 | Buy | $18.00 | N/A | Reinstates | 2 years ago |
Sarepta Therapeutics IncSRPT | 2 | Buy | $150.00 | N/A | Reinstates | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $50.00 | N/A | Reinstates | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $51.00 | N/A | Reinstates | 2 years ago |
Biogen IncBIIB | 1 | Buy | $283.00 | N/A | Upgrades | 2 years ago |
Passage Bio IncPASG | 5 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Ptc Therapeutics IncPTCT | 6 | Buy | $55.00 | N/A | Maintains | 3 years ago |
Kyntra Bio IncKYNB | 2 | Buy | $875.00 | N/A | Upgrades | 3 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $35.00 | N/A | Downgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 8 years ago |
Sage Therapeutics IncSAGE | 1 | Buy | $82.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.